Safe Streets and Communities Act (S.C. 2012, c. 1)

Assented to 2012-03-13

Marginal note:1999, c. 5, s. 49(1)
  •  (1) The portion of subsection 10(2) of the Act before paragraph (a) is replaced by the following:

    • Marginal note:Factors to take into consideration

      (2) If a person is convicted of a designated substance offence for which the court is not required to impose a minimum punishment, the court imposing sentence on the person shall consider any relevant aggravating factors including that the person

  • (2) Section 10 of the Act is amended by adding the following after subsection (3):

    • Marginal note:Drug treatment court program

      (4) A court sentencing a person who is convicted of an offence under this Part may delay sentencing to enable the offender

      • (a) to participate in a drug treatment court program approved by the Attorney General; or

      • (b) to attend a treatment program under subsection 720(2) of the Criminal Code.

    • Marginal note:Minimum punishment

      (5) If the offender successfully completes a program under subsection (4), the court is not required to impose the minimum punishment for the offence for which the person was convicted.

 Schedule I to the Act is amended by adding the following after item 18:

  • 19. 
    Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
    • (1) 
      amphetamine (α-methylbenzene-ethanamine)
    • (2) 
      N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
    • (3) 
      4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
    • (4) 
      3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
    • (5) 
      2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
    • (6) 
      4-methoxyamphetamine (4-methoxy-α-methylbenzene­ethanamine)
    • (7) 
      2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzene­ethanamine)
    • (8) 
      N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
    • (9) 
      4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (10) 
      5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzo­dioxole-5-ethanamine)
    • (11) 
      N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
    • (12) 
      N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzo­dioxole-5-ethanamine)
    • (13) 
      4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (14) 
      4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
    • (15) 
      4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
    • (16) 
      4-ethoxyamphetamine (4-ethoxy-α-methylbenzene­ethanamine)
    • (17) 
      Benzphetamine (N-benzyl-N,α-dimethylbenzene­ethanamine)
    • (18) 
      N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzo­dioxole-5-ethanamine)
    • (19) 
      N-(2-Hydroxyethyl)-α-meth-ylbenzene­ethanamine
    • (20) 
      N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxyla­mine)
    • (21) 
      3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzene­ethanamine)
  • 20. 
    Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives
  • 21. 
    4-hydroxybutanoic acid (GHB) and any of its salts